₹521.15
−0.17%NSE close, 16 Nov 2026
−0.23%
Lincoln Pharmaceuticals is a small cap company, listed on NSE under the symbol LINCOLN. At ₹521.15 a share, the market values the whole company at ₹1,044 crore.
In FY26, it reported sales of ₹671 crore and a net profit of ₹88 crore, an operating margin of 14.6%. Over the last three years, sales grew 9.6% a year and net profit grew 6.4% a year.
The market values the company at 10.8 times its profit over the last twelve months and 1.29 times its book value; its return on equity is 11.9% and it has almost no borrowings.
Promoters hold 49.78% of the shares. Foreign institutions hold 4.55%, and domestic institutions, mutual funds among them, 0.02%.
Over the past year the share price has fallen 0.4%, and it is 32.3% below its 52-week high.
₹ crore. Consolidated figures.
The financial results for the period ended September 30, 2026.
Minutes of 32nd Annual general meeting held on September 30, 2026.
A copy of Voting Results of Annual General Meeting held on September 30, 2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 146 | 142 | 147 | 161 | 147 | 168 | 154 | 163 | 166 | 187 | 177 | 191 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 117 | 124 | 125 | 133 | 123 | 141 | 130 | 138 | 143 | 162 | 150 | 168 |
| Operating profit | 29.7 | 18.4 | 22.7 | 28.4 | 23.7 | 26.7 | 23.8 | 25.4 | 23.6 | 24.9 | 27.4 | 23.7 |
| Operating margin | 20.3% | 12.9% | 15.4% | 17.6% | 16.1% | 15.9% | 15.4% | 15.6% | 14.2% | 13.3% | 15.5% | 12.4% |
| Other income | 11.0 | 7.0 | 10.4 | 10.0 | 9.0 | −6.9 | 15.3 | 7.2 | 15.2 | −4.2 | 24.3 | 9.5 |
| Interest | 0.2 | 0.5 | 0.4 | 0.4 | 0.7 | 0.4 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 |
| Depreciation | 2.8 | 2.7 | 3.2 | 3.2 | 3.2 | 3.2 | 3.5 | 3.6 | 3.7 | 3.7 | 3.9 | 3.9 |
| Profit before tax | 37.7 | 22.2 | 29.5 | 34.8 | 28.7 | 16.3 | 35.4 | 28.8 | 34.7 | 16.7 | 47.6 | 29.0 |
| Tax | 9.7 | 3.6 | 5.8 | 8.5 | 7.9 | 4.7 | 7.7 | 8.8 | 6.1 | 5.1 | 11.3 | 8.6 |
| Net profit | 28.0 | 18.6 | 23.7 | 26.3 | 20.8 | 11.6 | 27.7 | 20.0 | 28.6 | 11.6 | 36.2 | 20.4 |
| EPS (₹) | 14.00 | 9.28 | 11.82 | 13.15 | 10.37 | 5.78 | 13.82 | 9.98 | 14.28 | 5.81 | 18.09 | 10.20 |
₹ crore, financial years to March.
| Line | FY20 S | FY21 S | FY22 S | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 376 | 413 | 472 | 510 | 581 | 623 | 671 |
| Expenses | 317 | 332 | 377 | 421 | 481 | 522 | 573 |
| Operating profit | 59.4 | 81.4 | 95.5 | 89.2 | 99.9 | 101 | 97.7 |
| Operating margin | 15.8% | 19.7% | 20.2% | 17.5% | 17.2% | 16.3% | 14.6% |
| Other income | 12.1 | 6.8 | 10.0 | 22.5 | 34.4 | 22.5 | 33.5 |
| Interest | 2.0 | 1.4 | 1.5 | 2.0 | 1.5 | 1.9 | 1.0 |
| Depreciation | 5.5 | 5.7 | 8.1 | 9.2 | 10.6 | 12.9 | 14.5 |
| Profit before tax | 64.1 | 81.0 | 95.9 | 100 | 122 | 109 | 116 |
| Tax | 14.5 | 20.6 | 26.6 | 27.6 | 28.9 | 26.8 | 27.7 |
| Net profit | 49.6 | 60.4 | 69.4 | 72.9 | 93.3 | 82.4 | 87.9 |
| EPS (₹) | 24.78 | 30.20 | 34.63 | 36.39 | 46.58 | 41.11 | 43.88 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 76.2 | 93.0 | 106 | 37.2 |
| From investing | −78.1 | −79.0 | −98.4 | −35.5 |
| From financing | −2.6 | −6.4 | 0.2 | −1.9 |
| Spent on fixed assets | −45.5 | −19.0 | −25.4 | −38.4 |
| Free cash flow | 30.7 | 74.0 | 80.9 | −1.2 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | 13.2% | 14.6% | 14.7% | 14.3% | 16.1% | 13.2% | 13.1% |
| Operating margin | 15.8% | 19.7% | 20.2% | 17.5% | 17.2% | 16.3% | 14.6% |
| Return on equity | – | – | – | 14.5% | 15.7% | 12.3% | 11.6% |
| Return on capital employed | – | – | – | 20.3% | 20.8% | 16.5% | 15.3% |
| Return on assets | – | – | – | 12.4% | 13.3% | 10.3% | 9.9% |
| Debt to equity | – | – | – | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest coverage | 33.30 | 57.30 | 67.20 | 50.50 | 84.70 | 59.10 | 115.50 |
| Debt to assets | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 |
| Current ratio | – | – | – | 5.08 | 4.84 | 4.71 | 5.25 |
| Quick ratio | – | – | – | 4.11 | 4.00 | 3.97 | 4.53 |
| Cash ratio | – | – | – | 0.07 | 0.06 | 0.13 | 0.19 |
| Asset turnover | – | – | – | 0.87 | 0.83 | 0.78 | 0.75 |
| Fixed asset turnover | – | – | – | 3.40 | 3.24 | 3.43 | 3.53 |
| Inventory turnover | – | – | – | – | 3.60 | 3.70 | 3.90 |
| Receivables turnover | – | – | – | 3.70 | 3.60 | 3.70 | 4.20 |
| Gross margin | – | – | – | – | 52.1% | 53.3% | 53.6% |
| Cash from operations to profit | – | – | 110.0% | – | – | 113.0% | 121.0% |
| Effective tax rate | 22.6% | 25.4% | 27.7% | 27.4% | 23.7% | 24.6% | 24.0% |
Proceedings of Annual General Meeting held on September 30, 2026
Intimation regarding dispatch of physical communication to the Shareholders who have not registered their email address.
Notice of Annual General Meeting to be held on September 30, 2026.
Record date for the purpose of Dividend is 11-Sep-2026.
The financial results for the period ended Jun 30, 2026.